Home LiteratureArticle Details
PMID: 9407038 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

DNA damage induces phosphorylation of the amino terminus of p53.

Genes & development ·Vol. 11 ·No. 24 ·1997-12-15 ·Pages 3471-81

Siliciano JD, Canman CE, Taya Y, Sakaguchi K, Appella E, Kastan MB

Abstract

Data are presented demonstrating that DNA damage leads to specific post-translational modifications of p53 protein. Using two-dimensional peptide mapping of in vivo radiolabeled p53 tryptic phosphopeptides, recombinant truncated p53 protein, and synthetic p53 tryptic peptides, a unique p53 phosphopeptide was identified after exposure of ML-1 cells to ionizing irradiation. This peptide represents the first 24 amino acids of p53 and contains three phosphorylated serine residues. A specific p53 phosphopeptide antibody identified serine-15 as one of the two serines in p53 that becomes phosphorylated following DNA damage induced by either ionizing irradiation (IR) or ultraviolet (UV) irradiation in multiple cell types. IR-induced phosphorylation of p53 does not affect the kinetics of p53 binding to or dissociating from DNA as assessed by electrophoretic mobility-shift assays. However, p53 phosphorylation induced by DNA damage correlates with enhanced transcription of downstream p53 target genes. Low levels of phosphoserine-15 p53 are detectable within 6 hr after IR in AT cells, whereas lymphoblasts from normal individuals exhibit this modification within 1 hr. In contrast, phosphorylation of p53 on serine-15 is similar in normal and AT cells after UV irradiation. Our results indicate that p53 is phosphorylated in response to DNA damage, that this de novo phosphorylation may be involved in the subsequent induction and activation of p53, and that although ATM affects the kinetics of p53 phosphorylation after IR, it is not absolutely required for phosphorylation of p53 on serine-15.

MeSH Terms
Ataxia Telangiectasia/genetics,radiotherapy Binding Sites Cells, Cultured Cyclin-Dependent Kinase Inhibitor p21 Cyclins/genetics,metabolism DNA/metabolism DNA Damage/radiation effects Electrophoresis/methods Humans Lymphocytes/metabolism,pathology,radiation effects Nuclear Proteins Peptide Fragments/immunology Phosphorylation Protein Processing, Post-Translational Proto-Oncogene Proteins/genetics,metabolism Proto-Oncogene Proteins c-mdm2 Serine/metabolism Signal Transduction Tumor Suppressor Protein p53/genetics,metabolism Ultraviolet Rays
Chemicals
CDKN1A protein, human Cyclin-Dependent Kinase Inhibitor p21 Cyclins Nuclear Proteins Peptide Fragments Proto-Oncogene Proteins Tumor Suppressor Protein p53 Serine DNA MDM2 protein, human Proto-Oncogene Proteins c-mdm2
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Siliciano J D
The Johns Hopkins School of Medicine, Oncology Center, Baltimore, Maryland 21205, USA. jsilicia@welchlink.welch.jhu.edu
Canman C E
Taya Y
Sakaguchi K
Appella E
Kastan M B
References (55)
55 references, click to expand
  1. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells.
    Mol Cell Biol. 1984 Sep;4(9):1689-94 PMID: 6092932
  2. A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage.
    Genes Dev. 1996 Apr 15;10(8):934-47 PMID: 8608941
  3. A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis.
    Int J Pept Protein Res. 1990 Sep;36(3):255-66 PMID: 2279849
  4. Participation of p53 protein in the cellular response to DNA damage.
    Cancer Res. 1991 Dec 1;51(23 Pt 1):6304-11 PMID: 1933891
  5. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates.
    Methods Enzymol. 1991;201:110-49 PMID: 1943760
  6. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.
    Cell. 1992 Jun 26;69(7):1237-45 PMID: 1535557
  7. Phosphorylation of the p53 tumour-suppressor protein at three N-terminal sites by a novel casein kinase I-like enzyme.
    Oncogene. 1992 Jul;7(7):1361-9 PMID: 1620549
  8. Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53.
    Mol Cell Biol. 1992 Nov;12(11):5041-9 PMID: 1406679
  9. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.
    Cell. 1992 Nov 13;71(4):587-97 PMID: 1423616
  10. Regulation of the specific DNA binding function of p53.
    Cell. 1992 Nov 27;71(5):875-86 PMID: 1423635
  11. Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100b-binding protein.
    Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11627-31 PMID: 1454855
  12. Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression.
    Oncogene. 1993 Jun;8(6):1519-28 PMID: 8502477
  13. Mapping of the p53 and mdm-2 interaction domains.
    Mol Cell Biol. 1993 Jul;13(7):4107-14 PMID: 7686617
  14. Sequence-specific DNA binding by p53: identification of target sites and lack of binding to p53 - MDM2 complexes.
    EMBO J. 1993 Jul;12(7):2799-808 PMID: 8334996
  15. WAF1, a potential mediator of p53 tumor suppression.
    Cell. 1993 Nov 19;75(4):817-25 PMID: 8242752
  16. Ionizing radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells.
    Oncogene. 1993 Dec;8(12):3307-12 PMID: 8247533
  17. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways.
    Mol Cell Biol. 1994 Mar;14(3):1815-23 PMID: 8114714
  18. Phosphorylation of the tumor suppressor protein p53 by mitogen-activated protein kinases.
    J Biol Chem. 1994 Mar 25;269(12):9253-60 PMID: 7510706
  19. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain.
    Cell. 1994 Mar 25;76(6):1025-37 PMID: 8137421
  20. Immunochemical analysis of the interaction of p53 with MDM2;--fine mapping of the MDM2 binding site on p53 using synthetic peptides.
    Oncogene. 1994 Sep;9(9):2523-9 PMID: 8058315
  21. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status.
    Mol Cell Biol. 1994 Sep;14(9):6264-77 PMID: 8065358
  22. The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia.
    Cancer Res. 1994 Oct 1;54(19):5054-8 PMID: 7923116
  23. Cell cycle control and cancer.
    Science. 1994 Dec 16;266(5192):1821-8 PMID: 7997877
  24. p53: puzzle and paradigm.
    Genes Dev. 1996 May 1;10(9):1054-72 PMID: 8654922
  25. In vivo ubiquitination and proteasome-mediated degradation of p53(1).
    Cancer Res. 1996 Jun 1;56(11):2649-54 PMID: 8653711
  26. p53-dependent cell cycle arrests are preserved in DNA-activated protein kinase-deficient mouse fibroblasts.
    Cancer Res. 1996 Jul 1;56(13):2940-4 PMID: 8674045
  27. p53 in growth control and neoplasia.
    Biochim Biophys Acta. 1996 Jun 7;1287(2-3):77-102 PMID: 8672531
  28. Functional interaction between p53, the TATA-binding protein (TBP), andTBP-associated factors in vivo.
    Mol Cell Biol. 1996 Aug;16(8):4295-304 PMID: 8754830
  29. V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors.
    Genes Dev. 1996 Aug 15;10(16):2038-54 PMID: 8769647
  30. Mutations in the p53 and SCID genes cooperate in tumorigenesis.
    Genes Dev. 1996 Aug 15;10(16):2055-66 PMID: 8769648
  31. Biochemical and genetic defects in the DNA-dependent protein kinase in murine scid lymphocytes.
    Mol Cell Biol. 1996 Oct;16(10):5507-17 PMID: 8816463
  32. The casein kinase 1 alpha gene of Drosophila melanogaster is developmentally regulated and the kinase activity of the protein induced by DNA damage.
    J Cell Sci. 1996 Jul;109 ( Pt 7):1847-56 PMID: 8832407
  33. Dual roles of ATM in the cellular response to radiation and in cell growth control.
    Genes Dev. 1996 Oct 1;10(19):2401-10 PMID: 8843193
  34. Ataxia-telangiectasia and the ATM gene: linking neurodegeneration, immunodeficiency, and cancer to cell cycle checkpoints.
    J Clin Immunol. 1996 Sep;16(5):254-60 PMID: 8886993
  35. Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors.
    Science. 1996 Nov 15;274(5290):1194-7 PMID: 8895468
  36. DNA-dependent protein kinase is not required for accumulation of p53 or cell cycle arrest after DNA damage.
    Cancer Res. 1997 Jan 1;57(1):68-74 PMID: 8988043
  37. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.
    EMBO J. 1996 Dec 16;15(24):7060-9 PMID: 9003781
  38. Conformation-dependent phosphorylation of p53.
    Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1686-91 PMID: 9050839
  39. p53 and ATM: cell cycle, cell death, and cancer.
    Adv Cancer Res. 1997;71:1-25 PMID: 9111862
  40. Mdm2 promotes the rapid degradation of p53.
    Nature. 1997 May 15;387(6630):296-9 PMID: 9153395
  41. Regulation of p53 stability by Mdm2.
    Nature. 1997 May 15;387(6630):299-303 PMID: 9153396
  42. The CDK7-cycH-p36 complex of transcription factor IIH phosphorylates p53, enhancing its sequence-specific DNA binding activity in vitro.
    Mol Cell Biol. 1997 Oct;17(10):5923-34 PMID: 9315650
  43. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2.
    Cell. 1997 Oct 31;91(3):325-34 PMID: 9363941
  44. p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60.
    Science. 1995 Jan 6;267(5194):100-4 PMID: 7809597
  45. Defect in radiation signal transduction in ataxia-telangiectasia.
    Int J Radiat Biol. 1994 Dec;66(6 Suppl):S151-6 PMID: 7530754
  46. Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases.
    J Biol Chem. 1995 Mar 10;270(10):5405-11 PMID: 7534296
  47. p53 is phosphorylated in vitro and in vivo by an ultraviolet radiation-induced protein kinase characteristic of the c-Jun kinase, JNK1.
    J Biol Chem. 1995 Mar 10;270(10):5511-8 PMID: 7890669
  48. Growth factor modulation of p53-mediated growth arrest versus apoptosis.
    Genes Dev. 1995 Mar 1;9(5):600-11 PMID: 7698649
  49. Serine phosphorylation in the NH2 terminus of p53 facilitates transactivation.
    Cancer Res. 1995 Jun 1;55(11):2410-7 PMID: 7757994
  50. A single ataxia telangiectasia gene with a product similar to PI-3 kinase.
    Science. 1995 Jun 23;268(5218):1749-53 PMID: 7792600
  51. Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases.
    Nature. 1995 Jul 6;376(6535):88-91 PMID: 7596441
  52. ATM-related genes: what do they tell us about functions of the human gene?
    Cell. 1995 Sep 8;82(5):685-7 PMID: 7671296
  53. p53 is required for both radiation-induced differentiation and rescue of V(D)J rearrangement in scid mouse thymocytes.
    Genes Dev. 1996 Mar 1;10(5):553-65 PMID: 8598286
  54. Phosphorylation of p53 at the casein kinase II site selectively regulates p53-dependent transcriptional repression but not transactivation.
    Nucleic Acids Res. 1996 Mar 15;24(6):1119-26 PMID: 8604347
  55. Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2.
    Proc Natl Acad Sci U S A. 1990 Jun;87(12):4766-70 PMID: 2141171
Article Info
Journal
Genes & development
Abbr.
Genes Dev
ISSN
0890-9369
Published
1997-12-15
Pages
3471-81
Language
English
Region
United States
NLM ID
8711660
PMCID
PMC316806
Subset
IM
Grants
NIEHS NIH HHS · ES05777 · United States
NCI NIH HHS · CA71387 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com